Physician profile
Raul Jimenez
NPI 1649267923
$17,057.80
in general payments reported to CMS, 2019-2025
35 companies · $3,790 in 2025
The $3,790 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,065 · 2020: $1,101 · 2021: $1,091 · 2022: $874 · 2023: $4,558 · 2024: $1,579 · 2025: $3,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,075 · Travel and Lodging: $4,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,075.15 |
| Travel and Lodging | $4,852.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,002.48 | 2019-2025 | Aveir, Amplatzer Torqvue 45 X 45, Merlin@Home |
| Medtronic, INC. | $3,965.63 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $3,324.47 | 2019-2025 | General - Therapies, Farapulse, Watchman Flx |
| Medical Device Business Services, INC. | $2,136.37 | 2019 | |
| Medtronic Vascular, INC. | $1,223.71 | 2019-2020 | |
| Biosense Webster, INC. | $594.66 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.91 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $182.57 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $132.51 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $128.67 | 2023-2025 | Assure Wcd |
| Pfizer INC. | $123.31 | 2019-2024 | |
| Biotronik INC. | $121.75 | 2019-2021 | |
| Novo Nordisk INC | $110.87 | 2022-2025 | Ozempic |
| Actelion Pharmaceuticals US, INC. | $85.34 | 2023-2024 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $71.62 | 2023-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.41 | 2023-2025 | Jardiance |
| Irhythm Technologies, INC. | $57.98 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Altathera Pharmaceuticals LLC | $49.63 | 2024-2025 | Sotalol Hydrochloride |
| E.R. Squibb & Sons, L.L.C. | $43.77 | 2019-2023 | |
| Amgen INC. | $43.50 | 2019-2025 | Repatha |
| Elutia, INC. | $38.44 | 2022 | |
| Impulse Dynamics (USA) INC. | $37.67 | 2023 | Optimizer |
| Cardiva Medical, INC. | $37.50 | 2022 | |
| Cardiovascular Systems INC. | $35.99 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $34.28 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $31.33 | 2024 | |
| Volta Medical INC | $25.29 | 2024 | Vx1 |
| Infobionic, INC | $18.46 | 2020 | |
| Astellas Pharma US INC | $18.19 | 2020 | |
| Lilly USA, LLC | $16.45 | 2023 | Mounjaro |
| Philips North America LLC | $15.69 | 2024 | (Am5) Lead Management |
| Amarin Pharma, INC. | $13.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.97 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $12.87 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $10.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.